| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | -33.9% |
| Cost of Revenue | $164K | — | -87.4% |
| Gross Profit | $1.0M | — | +109.0% |
| R&D Expense | $23K | — | +58.0% |
| SG&A Expense | $855K | — | +4.6% |
| Operating Income | $129K | — | +172.0% |
| Pre-tax Income | $148K | — | +302.7% |
| Income Tax | $2K | — | -51.4% |
| Net Income | $146K | — | +1574.2% |
| EPS (Basic) | $0.01 | — | — |
| EPS (Diluted) | $0.01 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.6M | -5.3% | — |
| Inventory | $915K | -14.5% | — |
| Current Assets | $11.2M | +1.3% | — |
| Total Assets | $11.3M | +1.1% | -38.8% |
| Current Liabilities | $773K | +12.5% | -64.2% |
| Total Liabilities | $817K | +9.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$392K | — | — |
| Investing Cash Flow | -$306K | — | -38.9% |
| Financing Cash Flow | $20K | — | -90.9% |
| -62.2% |
| Stockholders' Equity | $10.5M | +0.5% | +601.8% |